Background: A safe and effective adjuvant plays an important role in the development of a vaccine.However,adjuvants licensed for administration in humans remain limited.Here,for the first time,we developed a novel combination adjuvant alum-polysaccharide-HH2(APH)with potent immunomodulating activities,consisting of alum,polysaccharide of Escherichia coli and the synthetic cationic innate defense regulator peptide HH2.Methods: The adjuvant effects of APH were examined using NY-ESO-1 protein-based vaccines in prophylactic and therapeutic models.We further determined the immunogenicity and anti-tumor effect of NY-ESO-1-APH(NAPH)vaccine using adoptive cellular/serum therapy in C57/B6 and nude mice.Cell-mediated and antibody-mediated immune responses were evaluated.Results: The APH complex significantly promoted antigen uptake,maturation and cross-presentation of dendritic cells and enhanced the secretion of TNF-α,MCP-1 and IFN-γ by human peripheral blood mononuclear cells compared with individual components.Vaccination of NAPH resulted in significant tumor regression or delayed tumor progression in prophylactic and therapeutic models.In addition,passive serum/cellular therapy potently inhibited tumor growth of NY-ESO-1-B16.Mice treated with NAPH vaccine produced higher antibody titers and greater antibody-dependent/independent cellular cytotoxicity.Therefore,NAPH vaccination effectively stimulated innate immunity,and boosted both arms of the adaptive humoral and cellular immune responses to suppress tumorigenesis and growth of melanoma.Conclusions: Our study revealed the potential application of APH complex as a novel immunomodulatory agent for vaccines against tumor refractory and growth.
Meng Li Huashan Shi Yandong Mu Zichao Luo Hailong Zhang Yang Wan Dongmei Zhang Lian Lu Ke Men Yaomei Tian Xiaozhe Wu Xiaoyan Liu Ying Pan Yingzi Fan Chaoheng Yu Bailing Zhou Rong Xiang Xiancheng Chen Li Yang
State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy,West China Hospita Department of Stomotology,Sichuan Academy of Medical Science & Sichuan Provincial People”s Hospital, Institute of Biomedical Engineering,School of Ophthalmology & Optometry and Eye Hospital,Wenzhou Med Department of Immunology,Nankai University School of Medicine,Tianjin,PR China